Immunocore Holdings plc - IMCR
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| Mar 06, 2026 | SCHEDULE 13G/A | T. Rowe Price Investment Management, Inc. | 6.0% | 3,041,904 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | T. Rowe Price Investment Management, Inc. | 11.8% | 5,961,227 | View |
| Nov 14, 2025 | SCHEDULE 13G | Bellevue Group AG | 5.6% | 2,796,803 | View |
| Nov 14, 2025 | SCHEDULE 13G | Bellevue Asset Management AG | 5.6% | 2,796,803 | View |
| Oct 24, 2025 | SCHEDULE 13G | TANG CAPITAL MANAGEMENT, LLC | 5.2% | 2,605,608 | View |
| Oct 24, 2025 | SCHEDULE 13G | KEVIN TANG | 5.2% | 2,605,608 | View |
| Oct 24, 2025 | SCHEDULE 13G | TANG CAPITAL PARTNERS, LP | 3.2% | 1,587,903 | View |
| Oct 24, 2025 | SCHEDULE 13G | TANG CAPITAL PARTNERS INTERNATIONAL, LP | 2.0% | 1,017,705 | View |
| Oct 24, 2025 | SCHEDULE 13G | TANG CAPITAL PARTNERS III, INC | 0.0% | 0 | View |
| Oct 24, 2025 | SCHEDULE 13G | TANG CAPITAL PARTNERS IV, INC | 0.0% | 0 | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.